Preclinical
Refoxy Pharmaceuticals is a biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.
Aignostics is a Berlin-based AI company that transforms multi-modal pathology data into insights for biopharmaceutical clients.
Biotech
Glox Therapeutics develops precision antibiotics targeting drug-resistant bacteria, with a focus on creating high-potency bacteriocins to selectively target and kill antibiotic-resistant Gram-negative pathogens while preserving the patient's microbiome.
Cancer treatment
Actym Therapeutics develops a new drug modality using genetically modified bacteria to initiate a selective immune response within the tumor microenvironment for treating solid tumors.